Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease.
Country of origin: USA
Click for Full Details: www.ncbi.nlm.nih.govA study conducted by Dr. Fukuda and colleagues, evaluated NAFLD as a risk marker for type 2 diabetes.1 The researchers evaluated data of >4500 patients who were part of a health checkup program over a 12-year period. In non-obese patients, NAFLD pushed the rate of diabetes from 3.2% to 14.4%, which is almost four times the rate of diabetes compared with that in people without NAFLD. For obese patients, NAFLD moved the rate of diabetes from 8% to 26.4%, which is a little over three times the rate of diabetes compared with that in people without NAFLD. The conclusion drawn by the researchers is that NAFLD is independent of BMI for prediction of diabetes.
Click for Full Details: www.ncbi.nlm.nih.gov
Cancer Navigator January 2018
Clinical Pain Advisor January 2018
Endocrinology Advisor January 2018
Breast Cancer Survivor January 2018
Cancer Emergency Response Tool - CERT January 2018
Rheumatology Advisor January 2018
Clinical Advisor January 2018
The Drugs & Bugs app January 2018
Managing Head Injury January 2018
inPracticeŽ Oncology January 2018